As I have said often someone hates this company and I don't know why. Im not asking for the moon but at least a 14 multiple.
A precedent is ok if the data is messy and you fail phase three trial, if its effective with minimal side affects
the size of the trial trumps all. Now there is no precedent until the FDA is faced with the same situation and proceeds to follow the same path. Never mind that the parents should have a choice,and faced with that choice Biomarine has no chance.
Our exports are less than 2% to China. our imports I believe are 1%. Will this not lead to more money coming to the USA. Oh well markets are never rational in the short term but when it comes to Gilead they are just down right nutty.
As investors in Gilead what are we to do? we wait and every quarter we blow earnings out of the water; the result , we spike and return to the old news, when will they make an acquisition. Meanwhile the price drifts lower and when the market is rocked we stumble the most even though we have one of the lowest PE for this year and even lower for the next. We get great news for a new use of an already approved drug in combination with another approved drug and the market shrugs. We await for the approval of a single dose for HIV and fewer side affects that can extend their patent for years to come. Most of the experts agree its just a matter of time before they have a cure for aides. Their Hep C drug achieves a cure in most cases within eight weeks and the market talks about the price. They have an incredible pipeline yet the street is obsessed with companies that have no drugs on the market and the likely hood that even if they get approved it might be years before they crack that billion blockbuster status. Gilead meanwhile makes billions a year on a drug that barely gets a mention, never mind the billions made every quarter by Harvoni. I don't want to sound conspiratorial but someone has a reason for holding this baby down.
I know and no one even mentions it. But I have to say, who writes those articles? unless you're well versed in pharma and medical jargon you would have no clue what they are talking about.
as all of you are aware that the FDA 99% of the time follows the opinion of the advisory board. The people who will benefit the most will be the patients. In terms of the stock the explosion will occur in November. As one analyst has stated either this stock will be over $100 by the end of the year or under $10.
that being the case most people on the street feel Baba is way under valued. Do you really think that with the Monopoly that Baba has in China that sooner or later they will not purchase a company to compete with Amazon in the USA? Watch and see, Ebay anyone.
I have been saying this over and over on this board the PE and Gilead's share price makes no sense. And you mostly compared Gild to companies in the sector that make money.
exactly; thats why going after SA is futile, it will only serve to drain money from the company's till. the company would have to open their books as well as research to the clowns at SA, that is why getting the SEC to find who profited from the attack piece and their relationship with the SA is a better approach. By the way, do sites like Yahoo and Google allow such companies like SA to spread this sort of trash?
Adam has been ignored for the last 2 months. Im losing money as well , but to be called a Comrad has a socialist tinge. With 20,000 shares I need at least $7.10 to break even,i will accept the moniquer if it gets there.